Clinical Trial Results: Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors [Phase 1]

View source ↗

Summary

Phase 1 feasibility study evaluating intra-tumoral lipopolysaccharide immunotherapy for intra-abdominal tumors has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer
• Malignancy

Drugs mentioned

• lipopolysaccharide immunotherapy

Snippet

Sponsor: Patrick Wagner, MD, FACS | Conditions: Abdominal Cancer, Malignancy | Phase 1 | Status: COMPLETED | Results posted: 2026-06-15